Document Detail

Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic.
MedLine Citation:
PMID:  19164937     Owner:  NLM     Status:  MEDLINE    
B-cell chronic lymphocytic leukemia (B-CLL) is the most common leukemia in human adults of the Western world and no definitive cure is yet available. The disease is characterized by accumulation of clonal malignant B lymphocytes resistant to apoptosis. Strategies to hit the anti-apoptotic drift of the Bcl-2 family in B-CLL cells are being explored. A novel peptidomimetic based on the BH3 domain of the pro-apoptotic protein Bim and recently shown to exert significant apoptotic activity on acute myeloid leukemia cells, both in vitro and in vivo, was assayed on ex-vivo derived leukemic cells from untreated B-CLL patients (n = 7). We found that this peptide, named 072RB, induced apoptosis of B-CLL samples at a concentration that does not affect viability of peripheral and bone marrow derived lymphocytes from healthy donors. Apoptosis was demonstrated by activation of Bak and Bax, externalization of plasma membranes phosphadydilserines, appearance of hypodiploid events in DNA flow cytometry histograms and was accompanied by dissipation of the mitochondrial transmembrane potential. Before the onset of marked apoptotic signs a progressive decline of the relevant anti-apoptotic proteins Bcl-X(L) and Mcl-1 could be observed. The negative control peptide 072RBL94A was ineffective for B-CLL cells, supporting the sequence specificity of 072RB activity. No relationship was found between responsiveness to 072RB and Mcl-1/Bcl-X(L) basal levels or decrease magnitude, possibly because of the limited sample size of the study. Altogether, we demonstrate that 072RB induces significant apoptosis of B-CLL cells subsequent to Bcl-X(L) and Mcl-1 downregulation.
Fabio Ghiotto; Franco Fais; Claudya Tenca; Valeria Tomati; Fortunato Morabito; Salvatore Casciaro; Anna Mumot; Gabriele Zoppoli; Ermanno Ciccone; Silvio Parodi; Silvia Bruno
Related Documents :
16041517 - Gaseous nitrogen oxide repressed benzo[a]pyrene-induced human lung fibroblast cell apop...
25453227 - Cell death and autophagy in tb.
20403207 - The conformation change of bcl-2 is involved in arsenic trioxide-induced apoptosis and ...
8624457 - Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cells.
21801407 - Is there a direct role for erythrocytes in the immune response?
8941667 - Langerhans cells express inducible nitric oxide synthase and produce nitric oxide.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-02-17
Journal Detail:
Title:  Cancer biology & therapy     Volume:  8     ISSN:  1555-8576     ISO Abbreviation:  Cancer Biol. Ther.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2010-04-12     Completed Date:  2010-07-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137842     Medline TA:  Cancer Biol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  263-71     Citation Subset:  IM    
Department of Experimental Medicine, Section of Human Anatomy, University of Genoa, Genoa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / drug effects*
Biological Markers / analysis
Cell Culture Techniques
Flow Cytometry
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy,  metabolism*
Peptides / pharmacology*
Phosphatidylserines / analysis
Proto-Oncogene Proteins c-bcl-2 / biosynthesis
bcl-2 Homologous Antagonist-Killer Protein / biosynthesis
bcl-2-Associated X Protein / biosynthesis
bcl-X Protein / biosynthesis
Reg. No./Substance:
0/072RB peptide; 0/BAK1 protein, human; 0/BCL2L1 protein, human; 0/Biological Markers; 0/Peptides; 0/Phosphatidylserines; 0/Proto-Oncogene Proteins c-bcl-2; 0/bcl-2 Homologous Antagonist-Killer Protein; 0/bcl-2-Associated X Protein; 0/bcl-X Protein; 0/myeloid cell leukemia sequence 1 protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Flies as the ointment: Drosophila modeling to enhance drug discovery.
Next Document:  Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPA...